Show simple item record

dc.contributor.authorDorothy, Abigaba
dc.contributor.authorYadesa, Tadele Mekuriya
dc.contributor.authorAtukunda, Esther Cathyln
dc.date.accessioned2022-05-31T13:22:44Z
dc.date.available2022-05-31T13:22:44Z
dc.date.issued2021
dc.identifier.citationDorothy, A., Yadesa, T. M., & Atukunda, E. (2021). Prevalence of medication errors and the associated factors: a prospective observational study among cancer patients at Mbarara regional referral hospital. Cancer Management and Research, 13, 3739.en_US
dc.identifier.urihttp://ir.must.ac.ug/xmlui/handle/123456789/2074
dc.description.abstractBackground: Medication error is one of the most common medical errors in the practice of modern medicine. Among cancer patients receiving chemotherapy, medication errors can be potentially harmful given the narrow therapeutic index, complex dosing, and toxic nature of anti-cancer drugs. Objective: This study aimed to determine the incidence and factors associated with medication errors among cancer patients. Methods: The study was a prospective observational study carried out at the cancer unit of Mbarara Regional Referral Hospital, Southwestern Uganda. The study included 110 participants, both adults and children receiving chemotherapy. The study was carried out for a period of five months from January to May 2020. A checklist was used to collect patient, medication, and disease information to identify the prescription, transcription, dispensing, and administration errors. Results: Of the 110 participants, 52 (47.3%) experienced a total of 78 medication errors (MEs). Of these, 33 (42.31%) were prescription errors, 29 (37.18%) administration errors, 9 (11.54%) transcription errors, and 7 (8.97%) dispensing errors. In the adjusted logistic regression of factors associated with medication errors, urban residents (aOR, 4.59; 95% CI, 1.08, 19.53, p= 0.039) and educated participants (at secondary level) (aOR, 10.51; 95% CI, 1.43, 77.14, p= 0.021) had a significantly higher risk of experiencing medication errors. Participants treated with alkylating agents (aOR, 2.87; 95% CI, 1.07, 7.72, p= 0.036) had a greater risk of experiencing medication errors when compared to other classes of chemotherapy. Conclusion: The incidence of medication errors among cancer patients was high in Mbarara Regional Referral Hospital. Prescription errors were the most common type of error followed by administration errors, and dispensing errors were the least common. Residence, education level, and alkylating agent chemotherapy were significantly associated with occurrence of medication errors.en_US
dc.description.sponsorshipPHARMBIOTRACen_US
dc.language.isoen_USen_US
dc.publisherCancer Management and Researchen_US
dc.subjectPrevalenceen_US
dc.subjectMedication erroren_US
dc.subjectAssociated factorsen_US
dc.subjectCanceren_US
dc.subjectMbararaen_US
dc.titlePrevalence of Medication Errors and the Associated Factors: A Prospective Observational Study Among Cancer Patients at Mbarara Regional Referral Hospitalen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record